Muscarinic agonists as enhancers of cognitive flexibility

Methods and compositions for treating a mental condition in a subject in need thereof, includes administering to a subject in need thereof an effective amount of a CDD-102A compound [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine], or a pharmaceutically acceptable salt or hydrate thereof pharmaceutically acceptable salt or hydrate thereof.
Download pdf
Abstract/Description: Methods and compositions for treating a mental condition in a subject in need thereof, includes administering to a subject in need thereof an effective amount of a CDD-102A compound [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine], or a pharmaceutically acceptable salt or hydrate thereof pharmaceutically acceptable salt or hydrate thereof.
Subject(s): A61K31/506
A61K31/00
Date Issued: 2017-01-24
Title: Muscarinic agonists as enhancers of cognitive flexibility.
Name(s): The University of Toledo The Board of Trustees of the University of Illinois, assignee
Messer, William S., inventor
Ragozzino, Michael, inventor
Type of Resource: text
Genre: patent
Publisher: United States Patent and Trademark Office
Other Date: Date Filed: 2012-04-30
Date Issued: 2017-01-24
Physical Form: application/pdf
Extent: 28 p.
Abstract/Description: Methods and compositions for treating a mental condition in a subject in need thereof, includes administering to a subject in need thereof an effective amount of a CDD-102A compound [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine], or a pharmaceutically acceptable salt or hydrate thereof pharmaceutically acceptable salt or hydrate thereof.
Identifier(s): utpatents-US9549928 (IID)
Patent No.: US9549928 (patno)
Appl. No.: 14/114646 (appno)
Subject(s): A61K31/506
A61K31/00
Held by: United States Patent and Trademark Office (USPTO) Public Search Facility
Location: University of Toledo Digital Repository
Rights Statement: No Copyright - United States
In Collections: